Viewing Study NCT05295394


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-02-12 @ 3:27 AM
Study NCT ID: NCT05295394
Status: WITHDRAWN
Last Update Posted: 2022-04-12
First Post: 2019-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
Sponsor: Pedro Cahn
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1 Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 naive infected patients View
None dual therapy View
None M184V mutation View